Not in the current Orange Book— This application is not listed in FDA's current Orange Book data files (no listed patents or exclusivities). Product and approval data shown are from FDA's Drugs@FDA database.
CABOZANTINIB S-MALATE | A213878 | MSN
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
Exelixis, Inc. v. MSN Laboratories Private Limited et al 1 patentANDA 213878cabozantinib | D. Del. | 2025-03-19 | Active | — |
Exelixis, Inc. v. MSN Laboratories Private Limited et al 7 patentsANDA 213878cabozantinib | D. Del. | 2022-07-18 | Terminated 2024-10-23 | — |
Exelixis, Inc. v. MSN Laboratories Private Limited et al 1 patentANDA 213878cabozantinib | D. Del. | 2019-10-29 | Terminated 2023-01-30 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
No patent or exclusivity listings for this strength.